 |
|
Variations in Hypertension Control in Indigent Rural Primary Care Clinics in North Carolina
Adam O. Goldstein, MD;
Timothy S. Carey, MD, MPH;
Denise Levis, RN, MPH;
Susan Madson, RN, BSN;
James Bernstein, MHA
Arch Fam Med. 1994;3(6):514-519.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Dustan HP, Caplan LR, Curry CL, et al. Report of the American Heart Association Task Force on the availability of cardiovascular drugs to the medically indigent. Circulation. 1992;85:849-860.
FREE FULL TEXT
2. Alderman MH. Which antihypertensive drugs first—and why! JAMA. 1992;267:2786-2787.
FREE FULL TEXT
3. Stason WB. Opportunities to improve the cost-effectiveness of treatment for hypertension. Hypertension. 1991;18(suppl_1):161-166.
4. Kaplan NM. Maximally reducing cardiovascular risk in the treatment of hypertension. Ann Intern Med. 1988;109:36-40.
FREE FULL TEXT
5. Moser M, Blaufox MD, Freis E, et al. Who really determines your patients' prescriptions? JAMA. 1991;265:498-500.
FREE FULL TEXT
6. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321:868-873.
ABSTRACT
7. Bostick RM, Luepker RV, Kofron PM, Pirie PL. Changes in physician practice for the prevention of cardiovascular disease. Arch Intern Med. 1991;151:478-484.
FREE FULL TEXT
8. Leon M; Weisfeld V, ed. Updated Report on Access to Health Care in the United States: Results of a 1986 Survey. Princeton, NJ: The Robert Wood Johnson Foundation; 1987. 9. Shulman NB, Martinez B, Brogan D, Carr AA, Miles CG. Financial costs as an obstacle to hypertension therapy. Am J Public Health. 1986;76:1105-1108.
FREE FULL TEXT
10. Roccella EJ. Cost of hypertension medications: is it a barrier to hypertension control? Geriatrics. 1989;44(suppl B):49-55.
PUBMED
11. Stason WB, Shephard DC, Perry HM Jr, Carmen BM, Nagurney JT, Mayer G. Effectiveness and costs of treating hypertension in VA clinics. J Hypertens. 1986;4(suppl 15):5395-5396.
12. Hypertension prevalence and the status of awareness, treatment, and control in the United States: final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension. 1985;7:457-468.
FREE FULL TEXT
13. 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
FREE FULL TEXT
14. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993;153:154-183.
FREE FULL TEXT
15. Zoler ML. Antihypertensives: a surfeit of choices. Med World News. October 1991:26-32. 16. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:408-413.
17. Black HR. Treatment of mild hypertension. JAMA. 1993;270:757-759.
FREE FULL TEXT
18. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. JAMA. 1993;270:713-724.
FREE FULL TEXT
19. Materson BJ, Reda DJ, Cushman WC, et al. Single drug therapy for hypertension in men. N Engl J Med. 1993;328:914-921.
FREE FULL TEXT
|
